GSK3-IN-4

CAS No. 748145-19-9

GSK3-IN-4( —— )

Catalog No. M35807 CAS No. 748145-19-9

GSK3-IN-4 is a GSK-3 inhibitor with IC50 of 0.101-1 μM of GSK-3α and GSK-3β in Calipe Assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 In Stock
5MG 255 In Stock
10MG 374 In Stock
25MG 545 In Stock
50MG 762 In Stock
100MG 1017 In Stock
500MG 2034 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK3-IN-4
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK3-IN-4 is a GSK-3 inhibitor with IC50 of 0.101-1 μM of GSK-3α and GSK-3β in Calipe Assay.
  • Description
    GSK3-IN-4 (compound 0715) is a potent GSK3 inhibitor. GSK3-IN-4 can be used for psychiatric disorder research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    748145-19-9
  • Formula Weight
    308.38
  • Molecular Formula
    C18H20N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C=2C(C3=C(NC2CC(C)(C)C1)NN=C3C)C=4C=CC=NC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Edward Scolnick, et al. Uses of paralog-selective inhibitors of gsk3 kinases. US20160375006A1.
molnova catalog
related products
  • IM-12

    IM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling.

  • GSK3a-IN-38

    GSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.

  • BIP-135

    BIP-135 is a potent and selective ATP-competitive GSK-3 inhibitor. With IC50s of 16 nM and 21 nM for GSK-3α and GSK-3β, respectively. BIP 135 exhibits neuroprotective effect.